Medicare Advantage Costs and Growth Largely Unexamined
A new KFF report examines the increased role of Medicare Advantage (MA) in the coverage landscape and the potential impact
A new KFF report examines the increased role of Medicare Advantage (MA) in the coverage landscape and the potential impact
The continuing resolution (CR) funding the federal government expires March 14. Earlier this week, the House passed legislation securing funding
Late Tuesday, House Republicans narrowly passed their budget resolution, paving the way for a reconciliation bill that advances key Trump
Medicaid is health insurance, long-term care coverage, and a workforce program all in one. It is a lifeline that helps
Earlier this month, Medicare Rights Center President Fred Riccardi participated in a panel on prior authorization in Medicare Advantage (MA)
Amid reports that lawmakers are considering changes to limit Medicaid spending and access as part of a broader legislative package
On January 27, the White House Office of Management and Budget (OMB) issued a memo ordering federal agencies to temporarily
On January 17, the U.S. Department of Health and Human Services (HHS) announced the 15 Part D drugs that will
This week, the Medicare Rights Center released our annual helpline trends report, Medicare Trends and Recommendations: An Analysis of 2023 Call
Under new legislation, New York will soon use eligibility information from the Part D Low-Income Subsidy (LIS) program, commonly known
A new KFF report examines the increased role of Medicare Advantage (MA) in the coverage landscape and the potential impact
The continuing resolution (CR) funding the federal government expires March 14. Earlier this week, the House passed legislation securing funding
Late Tuesday, House Republicans narrowly passed their budget resolution, paving the way for a reconciliation bill that advances key Trump
Medicaid is health insurance, long-term care coverage, and a workforce program all in one. It is a lifeline that helps
Earlier this month, Medicare Rights Center President Fred Riccardi participated in a panel on prior authorization in Medicare Advantage (MA)
Amid reports that lawmakers are considering changes to limit Medicaid spending and access as part of a broader legislative package
On January 27, the White House Office of Management and Budget (OMB) issued a memo ordering federal agencies to temporarily
On January 17, the U.S. Department of Health and Human Services (HHS) announced the 15 Part D drugs that will
This week, the Medicare Rights Center released our annual helpline trends report, Medicare Trends and Recommendations: An Analysis of 2023 Call
Under new legislation, New York will soon use eligibility information from the Part D Low-Income Subsidy (LIS) program, commonly known